BAP1: Insights and New Understandings - A/Prof Sarah Kummerfeld
Associate Professor Sarah Kummerfeld presents on BAP1 mutations in uveal melanoma at the 1st Australasian Ocular Melanoma Summit, held at the Garvan Institute of Medical Research in Sydney on May 3rd-4th, 2019.
The Australasian Ocular Melanoma Alliance (AOMA) presents the 1st Australasian Ocular Melanoma Summit. The AOMA group was founded in late 2017 by Melanoma and Skin Cancer Trials Ltd to support clinicians and researchers from all disciplines to develop, seek funding for, and collaborate on clinical trials in ocular melanoma.
Follow us at;
Australasian Ocular Melanoma Alliance - @AOMA_MASC
Melanoma and Skin Cancer Trials - @MASC_Trials
A/Prof Sarah Kummerfeld - @skummerf
For more information contact us at admin@masc.org.au
The event was sponsored/supported by;
Melanoma and Skin Cancer Trials Limited, The Garvan Institute of Medical Research and Kinghorn Cancer Centre, Melanoma Institute Australia, The Save Sight Institute, SydPath and Cancer Australia.
-
Category
No comments found